SEC Form 4 · accession 0001424422-18-000006
BioPharmX Corp · BPMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anja B Krammer
Director
Period of report
Oct 10, 2018
Accepted (ET)
Oct 12, 2018 · 8:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001504167
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Oct 10, 2018 | S | 102,500 | $0.19 | D | 2,397,500 | D | |
| Common stock | Oct 11, 2018 | S | 100,000 | $0.19 | D | 2,297,500 | D | |
| Common stock | Oct 12, 2018 | S | 297,500 | $0.19 | D | 2,000,000 | D |
Table II — derivative securities
No Table II lines on this filing.